GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
10.15
-0.81 (-7.35%)
Nov 21, 2024, 1:05 PM EST - Market open
GH Research Market Cap
GH Research has a market cap or net worth of $527.83 million as of November 21, 2024. Its market cap has increased by 22.99% in one year.
Market Cap
527.83M
Enterprise Value
409.12M
1-Year Change
22.99%
Ranking
Category
Stock Price
$10.15
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $527.83M, a decrease of -34.70%. That is a compound annual growth rate of -11.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 569.71M | 88.82% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mereo BioPharma Group | 501.56M |
| Altimmune | 501.02M |
| Astria Therapeutics | 498.31M |
| PureTech Health | 498.29M |
| Cartesian Therapeutics | 495.46M |
| Savara | 489.11M |
| Olema Pharmaceuticals | 484.68M |
| Community Health Systems | 481.91M |